HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cobra Moradian Selected Research

3- (4- (2- (3- chlorophenylamino)pyrimidin- 4- yl)pyridin- 2- ylamino)propanol

11/2021Drug repositioning based on gene expression data for human HER2-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cobra Moradian Research Topics

Disease

3Neoplasms (Cancer)
11/2021 - 01/2019
3Breast Neoplasms (Breast Cancer)
11/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

13- (4- (2- (3- chlorophenylamino)pyrimidin- 4- yl)pyridin- 2- ylamino)propanolIBA
11/2021
1human ERBB2 proteinIBA
11/2021
1mocetinostatIBA
11/2021
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
11/2021
1VorinostatFDA Link
11/2021
1alvocidib (flavopiridol)IBA
11/2021
1N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
11/2021
1CurcuminIBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1Dendrimers (Dendrons)IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Poly(amidoamine)IBA
01/2021
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2019
1Immunotoxins (Immunotoxin)IBA
01/2019
15' Untranslated Regions (5' UTR)IBA
01/2019

Therapy/Procedure

1Therapeutics
01/2019